COVID-19 Miniseries: The Safety of Convalescent Plasma

  • 17m 5s
  • Amit K. Ghosh, M.D., M.B.A., Michael J. Joyner, M.D.
  • Mayo Clinic Health Solutions
  • 2020

Convalescent plasma as a passive immunity strategy is not new. What nuances apply for it’s application to treating COVID-19? Is it safe? Is it efficacious? Dr. Michael Joyner, Principal Investigator for Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19, discusses what’s known about this treatment option, information that’s currently being gathered, and how you can get involved.

In this Audiobook

  • Mayo Clinic Talk with Doctor Michael Joyner on the Safety of Convalescent Plasma

YOU MIGHT ALSO LIKE

Course Mayo Clinic Q&A: Managing COVID-19 Inpatients
Rating 4.3 of 30 users Rating 4.3 of 30 users (30)
Course Mayo Clinic COVID-19 Live Webinar Series - January 20, 2021: Supply Chain Considerations for Delivering the COVID-19 Vaccine
Rating 4.4 of 34 users Rating 4.4 of 34 users (34)
Audiobook COVID-19 Miniseries: A Comprehensive Update on COVID-19